After the slow pick-up of the $220 One Laptop Per Child Project, and an uncertainty over the $35 laptop called Sakshat, the government is now experimenting with another model—to dole out computers on rent to spread IT literacy in the country. Under a pilot program to be launched by the ministry of IT & communications, computers specially built for rural areas will be deployed in five locations, and then rented...

The Supreme Court's directive to the Union government to distribute rotting grain to the poor free of cost was an “order” and the Bihar government must demand free grain from the Centre to alleviate the plight of the drought-hit people in the State, Communist Party of India (Marxist) general secretary Prakash Karat said here on Thursday. Despite the Prime Minister's reservations, the Centre must comply with the court order of August...

When noted economist Jean Dreze visited Surguja in Chhattisgarh a decade ago, its utterly non-functional Public Distribution System (PDS) looked like especially “designed to fail.” The National Advisory Committee member has written in a recent article that the ration shop owners illegally sold the grain meant for the poor and “hunger haunted the land.” But that was then. The economist was pleasantly shocked to see the transformation this time. “Ten years...

Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical...

No clarity on which authorities will be competent or which laws will be relevant: Ramesh He agrees with the compromise of Department of S&T as the nodal Ministry The Biotechnology Regulatory Authority of India (BRAI) will only deal with the safety and efficacy aspects of biotech products, leaving the controversial commercialisation aspect hanging in the air, according to the latest version of the BRAI Bill, 2010. The Bill, which was supposed to be...